Abacavir Impurity 19 | CAS 1378496-11-7 - Request Quote
Abacavir Impurity 19
| SZ CAT No: | SZ-A049057 |
| CAS No | 1378496-11-7 |
| Mol.F. | C4H5ClN4O |
| Mol.Wt. | 160.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Abacavir Impurity 19 is chemically 2,5-Diamino-6-chloropyrimidin-4-ol. Abacavir Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Abacavir Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abacavir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1378496-11-7
Purchase 1378496-11-7
Order 1378496-11-7
Enquire 1378496-11-7
price of 1378496-11-7
1378496-11-7 Supplier
1378496-11-7 Manufacturer
1378496-11-7 Exporter
buy high quality Abacavir Impurity 19
Purchase Abacavir Impurity 19
Abacavir Impurity 19 suppliers
Abacavir Impurity 19 manufacturers
Abacavir Impurity 19 price
Order Abacavir Impurity 19
Enquire Abacavir Impurity 19
Abacavir Impurity 19 cost
Abacavir Impurity 19 Supplier
Abacavir Impurity 19 Distributor
Abacavir Impurity 19 for Method Validation
Abacavir Reference Standard
Abacavir Impurity 19 for ANDA Filing
Abacavir Impurity 19 for Forced Degradation Studies
Abacavir Impurity 19 Identification Standards
Abacavir Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


